Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $33.93 USD
Change Today +3.01 / 9.73%
Volume 1.3M
OVAS On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michelle Dipp M.D., Ph.D.

Co-Founder, Chief Executive Officer and Director, OvaScience, Inc.
AgeTotal Calculated CompensationThis person is connected to 37 board members in 1 different organizations across 3 different industries.

See Board Relationships
38$5,629,030
As of Fiscal Year 2014

Background*

Dr. Michelle Dipp, M.D., Ph.D. co-founded OvaScience, Inc., in April 2011 and has been its Chief Executive Officer since June 2011. Dr. Dipp is a Co-Founder of Verastem, Inc., Alnara Pharmaceuticals, and FlexPharma. She is the Co-Founder and Advisor at Flex Pharma, Inc. She is also the Founder and Partner at Longwood Founders Management, LLC. She served as President OvaScience, Inc., from September 2011 to December 2014. She served as a Senior Vice President and Head ...

Read Full Background

Corporate Headquarters*

215 First Street
Cambridge, Massachusetts 02142

United States

Phone: 617-500-2802
Fax: --

Board Members Memberships*

2011-Present
Co-Founder, Chief Executive Officer and Director

Education*

PhD
University of Oxford
MD
University of Oxford

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Restricted Stock Awards$1,280,444
Exercisable Options232,156
Exercisable Options Value$8,415,747
Unexercisable Options807,157
Unexercisable Options Value$24,209,033
Total Value of Options$32,624,779
Total Number of Options1,039,313

Total Compensation*

Other Long Term Compensation$1,280,444
Total Calculated Compensation$5,629,030
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OVAS:US $33.93 USD +3.01

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OVASCIENCE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.